At a glance
ClinicalIndex Comparison RecordN/ACompleted· 90 enrolled
Drug / intervention
Probiotic group +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Can Lactobacillus Acidophilus Decrease the Risk of Postmenopausal in Women?
In Brief
A clinical study evaluating Probiotic group and Placebo group for Bone Loss and 2 related conditions. Completed, enrolled 90 participants across 1 site.
Detailed Summary
This study aims to evaluate the effect of Lactobacillus acidophilus supplementation on calcium status and bone densitometry in postmenopausal women in a randomized, double-blind placebo-controlled study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBone Loss, Post Menopausal Osteoporosis, Mineralization
CountriesPoland
CollaboratorsPoznan University of Medical Sciences
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartFeb 2022
First PostedApr 2022
Primary CompletionJul 2024
TodayJul 2026
First PostedApr 18, 2022
Enrollment StartFeb 1, 2022
Primary CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 4.2 years ago
Interventions
Probiotic groupdietary
The probiotic gorup is focused on the treatment of postmenopause osteoporosis women with a capsule cointained 1x10\^9 CFU of Lactobacillus acidophilus UALa-01™/day (30 people)
Placebo groupdietary
The group is assigned on the treatment of postmenopause osteoporosis women without probiotic intervention (30 people)